Evidence map›Paper›PMID 26978353›Full record

ReviewInternational journal of molecular sciences2016

Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy.

Lifeng Xiong, Jade L L Teng, Michael G Botelho, Regina C Lo, Susanna K P Lau, Patrick C Y Woo

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06128798 (A Randomized Controlled Trial on Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery.), which is not on this map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06128798 naunknown statusnot on this mapstarted 2023, after this paper: background citation

A Randomized Controlled Trial on Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery.

TypeinterventionalSponsorHospital Universiti Sains MalaysiaRan2023 to 2024Enrolled58ConditionsColorectal NeoplasmsArmsOral Impact, Nutren Optimum
3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 154 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. ArgT functions as an arginine transporter inJournal of bacteriology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Arginine at the host-pathogen interface.Infection and immunity · 2025
    Review
  15. Article
  16. Article
  17. Arginine utilization inInfection and immunity · 2025
    Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lifeng XiongDepartment of Microbiology, The University of Hong Kong, Hong Kong, China. lfxiong@hku.hk.
Jade L L TengDepartment of Microbiology, The University of Hong Kong, Hong Kong, China. llteng@hku.hk.
Michael G BotelhoFaculty of Dentistry, The University of Hong Kong, Hong Kong, China. botelho@hku.hk.
Regina C LoDepartment of Pathology, The University of Hong Kong, Hong Kong, China. reginalo@pathology.hku.hk.
Susanna K P LauDepartment of Microbiology, The University of Hong Kong, Hong Kong, China. skplau@hku.hk.
Patrick C Y WooDepartment of Microbiology, The University of Hong Kong, Hong Kong, China. pcywoo@hku.hk.
University of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibacterial resistance to infectious diseases is a significant global concern for health care organizations; along with aging populations and increasing cancer rates, it represents a great burden for government healthcare systems. Therefore, the development of therapies against bacterial infection and cancer is an important strategy for healthcare research. Pathogenic bacteria and cancer have developed a broad range of sophisticated strategies to survive or propagate inside a host and cause infection or spread disease. Bacteria can employ their own metabolism pathways to obtain nutrients from the host cells in order to survive. Similarly, cancer cells can dysregulate normal human cell metabolic pathways so that they can grow and spread. One common feature of the adaption and disruption of metabolic pathways observed in bacterial and cancer cell growth is amino acid pathways; these have recently been targeted as a novel approach to manage bacterial infections and cancer therapy. In particular, arginine metabolism has been illustrated to be important not only for bacterial pathogenesis but also for cancer therapy. Therefore, greater insights into arginine metabolism of pathogenic bacteria and cancer cells would provide possible targets for controlling of bacterial infection and cancer treatment. This review will summarize the recent progress on the relationship of arginine metabolism with bacterial pathogenesis and cancer therapy, with a particular focus on arginase and arginine deiminase pathways of arginine catabolism.

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsArginaseArginineBacteriaBacterial InfectionsDrug Resistance, BacterialGene Expression RegulationHumansHydrolasesNeoplasmsSignal TransductionAnti-Bacterial AgentsAntineoplastic AgentsArginaseArgininearginine deiminaseHydrolasesarginasearginine deiminasearginine metabolismbacterial pathogenesiscancer therapy

Identifiers

PMID26978353
PMCPMC4813224
OpenAlexW2295797336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.